Variant report
Variant | nsv519951 |
---|---|
Chromosome Location | chr13:96922191-96923515 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1927790 | chr13:96922191-96922192 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs118075018 | chr13:96922210-96922211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs577909349 | chr13:96922294-96922295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs186393775 | chr13:96922295-96922296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566850197 | chr13:96922344-96922345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537500966 | chr13:96922349-96922350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs4603419 | chr13:96922364-96922365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs748457 | chr13:96922449-96922450 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs150247003 | chr13:96922537-96922538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549547712 | chr13:96922564-96922565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs559275308 | chr13:96922572-96922573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs748458 | chr13:96922629-96922630 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551341295 | chr13:96922641-96922642 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188927521 | chr13:96922676-96922677 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536615476 | chr13:96922713-96922714 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9554333 | chr13:96922716-96922717 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs748459 | chr13:96922722-96922723 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs752328 | chr13:96922856-96922857 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs116901600 | chr13:96922860-96922861 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201596106 | chr13:96922867-96922868 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs398070404 | chr13:96922874-96922875 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs199894379 | chr13:96922875-96922876 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs752327 | chr13:96922935-96922936 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368216431 | chr13:96922964-96922965 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552689891 | chr13:96922970-96922971 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572505222 | chr13:96922984-96922985 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs370914441 | chr13:96922987-96922988 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs368386183 | chr13:96923021-96923022 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs535222235 | chr13:96923058-96923059 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs542484894 | chr13:96923083-96923084 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs578206084 | chr13:96923122-96923123 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs374516502 | chr13:96923146-96923147 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375820873 | chr13:96923158-96923159 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs77013093 | chr13:96923170-96923171 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs563672169 | chr13:96923189-96923190 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs752326 | chr13:96923203-96923204 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs138858460 | chr13:96923238-96923239 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559801164 | chr13:96923239-96923240 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528246095 | chr13:96923298-96923299 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs181678343 | chr13:96923322-96923323 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs370087684 | chr13:96923339-96923340 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564966324 | chr13:96923347-96923348 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530693803 | chr13:96923354-96923355 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs149489219 | chr13:96923450-96923451 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs186196481 | chr13:96923461-96923462 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs535851661 | chr13:96923464-96923465 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs74811313 | chr13:96923501-96923502 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs4381453 | chr13:96923515-96923516 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Wilms tumour | 21544195 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:96918600-96922200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr13:96921800-96925200 | Enhancers | Fetal Intestine Large | intestine |
3 | chr13:96922200-96922600 | Enhancers | Pancreas | Pancrea |
4 | chr13:96922200-96922800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
5 | chr13:96922200-96924800 | Enhancers | Fetal Intestine Small | intestine |
6 | chr13:96922600-96926600 | Weak transcription | Pancreas | Pancrea |
7 | chr13:96922800-96923200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
8 | chr13:96922800-96924000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr13:96923000-96923400 | Enhancers | H9 Cell Line | embryonic stem cell |
10 | chr13:96923000-96923400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr13:96923000-96923400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr13:96923000-96923400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr13:96923000-96924000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr13:96923200-96923400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
15 | chr13:96923400-96924200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |